Source: Pharmabiz

Terns Pharmaceuticals: Terns Pharma completes phase 1 study of TERN─101 to treat NASH

Terns Pharmaceuticals, a global biopharmaceutical company focused on discovering and developing innovative therapies to treat non─alcoholic steatohepatitis (NASH) and cancer, announced the completion of a phase

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Senthil Sundaram's photo - CEO of Terns

CEO

Senthil Sundaram

CEO Approval Rating

90/100

Terns is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer and liver diseases. Read more